FindTrial
Sign In

Postoperative Monitoring of Lung Cancer Patients Based on ctDNA

Postoperative Monitoring of Lung Cancer Patients Based on ctDNA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17011796
Enrollment
Unknown
Registered
2017-06-29
Start date
2017-07-20
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Case series:Nil

Sponsors

Sichuan Cancer Hospital and Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Resectable non-samll cell lung cancer patients of stage I, II and III.

Exclusion criteria

Exclusion criteria: Patients have resceived chemotherapy.

Design outcomes

Primary

MeasureTime frame
Tumor Burden;OS;DFS;—

Countries

China

Contacts

Public ContactJintao He

Sichuan Cancer Hospital and Institute

HJTabc3@126.com+86 13881749513

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026